
About this episode
Last month the UK’s Food Standards Authority slashed the recommended safe daily intake of cannabidiol (CBD) from 70mg to 10mg. An estimated one in 10 people in the UK have used products containing CBD, and many users believe it can help with ailments such as insomnia, anxiety and pain. But is there any evidence for the supposed benefits, and what’s behind the FSA’s decision? Ian Sample talks to Dr Will Lawn of Kings College University, who has studied the health effects of CBD, to find out. Help support our independent journalism at theguardian.com/sciencepod
Get every episode summarized
Each time Science Weekly publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Science Weekly

Muons, massive waves and restored sight: the winners at the ‘Oscars of science’
Science Weekly
Apr 23, 202616:19failed

Mythos: are fears over new AI model panic or PR?
Science Weekly
Apr 21, 202615:50failed

The surprising value of boring chats, ‘super El Niño’ and Alzheimer’s evidence r...
Science Weekly
Apr 16, 202620:45failed

Helium: the invisible gas that powers AI, and why it’s in short supply
Science Weekly
Apr 14, 202616:19failed